Sat, Sep 20, 2014, 3:36 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Catalyst Pharmaceutical Partners Inc. Message Board

  • guw1 guw1 Mar 11, 2014 8:46 AM Flag

    As Close To A Lay-up As You Can Get In The Biotech Game.

    For the skeptics and those who are understandably skittish-nervous, please note that CPRX is as close to a lay-up as you can get in the biotech lotto game. Phase 3 trial announcement is nearing in Q3. Enrollment with 23 active sites is sufficient to complete the trial, with or without the last remaining site, as Dr. Selvaraju of Aegis has pointed out. Take a look at CHTP. Catalyst will mirror CHTP as Northera is akin to Firdapse.
    And lest we forget, "breakthrough therapy" designation granted on 8/23/2013 means that Catalyst will be working CLOSELY with the FDA to ensure the phase 3 trial is successful. Reread the breakthrough therapy announcement. That Firdapse is already approved in Europe is a bonus. Do not pay attention to the mm's/speculators who deliberately manipulate low priced stocks to their advantage to accumulate shares sold by nervous retail players. CPRX will see $2.50 soon enough and like CHTP, is at least a double or triple from here by year end. GLTA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.09-0.03(-0.96%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TC PipeLines, LP
NYSEFri, Sep 19, 2014 4:00 PM EDT
Oracle Corporation
NYSEFri, Sep 19, 2014 4:00 PM EDT